Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Search TravelDoctorOnline

Authors: Mauldin J,Carbone K,Hsu H,Yolken R,Rubin S,
Address: Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland 20892, USA.
Journal: J Clin Microbiol.


Publication: 2005 Sep;43(9):4847-51.
Free Text: Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

abstract

Mumps virus-neutralizing antibodies are believed to be the most predictable surrogate marker of protective immunity. However, assays used to detect neutralizing antibodies, such as the plaque reduction neutralization (PRN) assay, are labor- and time-intensive and consequently are often supplanted by the more rapid and inexpensive enzyme immunoassay (EIA) technique. For virus infections for which international antibody standards exist and are bridged to clinical studies of protection (e.g., measles and rubella), the EIA has been successfully used to determine immune surrogate endpoints, yet no such international reference exists for mumps serology. Since both virus-neutralizing and nonneutralizing antibodies are measured in the EIA, in the absence of a mumps serological standard, the EIA may be prone to yielding false-positive results when utilized for assessing surrogate markers of protective immunity. Moreover, since mumps virus-specific antibody titers are generally low in comparison to antibody levels induced by other viruses and EIA procedures often employ relatively high serum dilution factors, the EIA may be prone to yielding false-negative results. To examine these issues, a PRN assay and two commercially available EIA kits were used to evaluate wild-type mumps virus serological responses in human serum samples from the pre-mumps vaccine era. Our results indicate that the PRN assay is a more sensitive and specific method of measuring serological responses to wild-type mumps virus.



Related Articles
Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
J Clin Microbiol. 1995
Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.
Ratnam S, Gadag V, West R, Burris J, Oates E, Stead F, Bouilianne N. J Clin Microbiol. 1995 Apr; 33(4):811-5.
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
Clin Vaccine Immunol. 2008
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
Haralambieva IH, Ovsyannikova IG, Vierkant RA, Poland GA. Clin Vaccine Immunol. 2008 Jul; 15(7):1054-9. Epub 2008 May 7.
Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
J Infect Dis. 2008
Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
Rubin SA, Qi L, Audet SA, Sullivan B, Carbone KM, Bellini WJ, Rota PA, Sirota L, Beeler J. J Infect Dis. 2008 Aug 15; 198(4):508-15.
Review [Problems related to determination of reference interval and clinical decision limit in enzyme immunoassay].
Nihon Rinsho. 1995
Review [Problems related to determination of reference interval and clinical decision limit in enzyme immunoassay].
Ichihara K. Nihon Rinsho. 1995 Sep; 53(9):2220-30.
Review [MUMPS].
Nihon Rinsho. 2003
Review [MUMPS].
Takita S. Nihon Rinsho. 2003 Feb; 61 Suppl 2:271-5.
Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
PLoS One. 2012
Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.
Poethko-Müller C, Mankertz A. PLoS One. 2012; 7(8):e42867. Epub 2012 Aug 6.
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
Vaccine. 2011
Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.
Stermole BM, Grandits GA, Roediger MP, Clark BM, Ganesan A, Weintrob AC, Crum-Cianflone NF, Ferguson TM, Macalino GE, Landrum ML. Vaccine. 2011 Apr 5; 29(16):2874-80. Epub 2011 Feb 23.
Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice.
Immunology. 2010
Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice.
Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, Leroux-Roels G. Immunology. 2010 Sep; 131(1):33-9. Epub 2010 Jun 25.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.